These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10975803

  • 21. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H, Sakai T, Tsuneoka H, Imanishi K, Saito S.
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [Abstract] [Full Text] [Related]

  • 22. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
    Kwak HJ, Yang YS, Pae HO, Kim YM, Chung HT.
    Mol Cells; 2001 Oct 31; 12(2):178-84. PubMed ID: 11710518
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A, Usui Y, Takeuchi M, Hattori T, Kezuka T, Suzuki J, Okunuki Y, Iwasaki T, Haino M, Matsushima K, Usui M.
    Invest Ophthalmol Vis Sci; 2005 Oct 31; 46(10):3753-60. PubMed ID: 16186359
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
    Xu H, Rizzo LV, Silver PB, Caspi RR.
    Cell Immunol; 1997 May 25; 178(1):69-78. PubMed ID: 9184700
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
    Ito D, Ogasawara K, Iwabuchi K, Inuyama Y, Onoé K.
    J Immunol; 2000 Feb 01; 164(3):1230-5. PubMed ID: 10640735
    [Abstract] [Full Text] [Related]

  • 31. The role of costimulatory molecules B7-1 and B7-2 in mice with experimental autoimmune uveoretinitis.
    Fukai T, Okada AA, Sakai J, Kezuka T, Keino H, Usui M, Yagita H, Okumura K, Mizuguchi J.
    Graefes Arch Clin Exp Ophthalmol; 1999 Nov 01; 237(11):928-33. PubMed ID: 10541904
    [Abstract] [Full Text] [Related]

  • 32. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
    Iwata D, Kitaichi N, Miyazaki A, Iwabuchi K, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K, Todo S, Ishida S, Onoé K.
    Invest Ophthalmol Vis Sci; 2010 Apr 01; 51(4):2077-84. PubMed ID: 19907030
    [Abstract] [Full Text] [Related]

  • 33. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
    Grajewski RS, Hansen AM, Agarwal RK, Kronenberg M, Sidobre S, Su SB, Silver PB, Tsuji M, Franck RW, Lawton AP, Chan CC, Caspi RR.
    J Immunol; 2008 Oct 01; 181(7):4791-7. PubMed ID: 18802082
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.
    Wu Y, Wang Y, Zhong C, Li Y, Li X, Sun B.
    Int Immunopharmacol; 2003 Oct 01; 3(10-11):1457-65. PubMed ID: 12946442
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C, Fujimoto M, Nomura S, Serada S, Nakai K, Ohguro N, Nishida K, Naka T.
    Exp Eye Res; 2015 Nov 01; 140():53-64. PubMed ID: 26297802
    [Abstract] [Full Text] [Related]

  • 39. Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.
    Sartani G, Silver PB, Strassmann G, Chan CC, Caspi RR.
    Curr Eye Res; 1995 Oct 01; 14(10):887-96. PubMed ID: 8549154
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.